Opus Genetics, Inc.
IRD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10,992 | $19,049 | $39,850 | $589 |
| % Growth | -42.3% | -52.2% | 6,665.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $10,992 | $19,049 | $39,850 | $589 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $26,851 | $17,653 | $14,355 | $15,173 |
| G&A Expenses | $18,215 | $11,959 | $7,269 | $8,121 |
| SG&A Expenses | $18,215 | $11,959 | $7,269 | $8,121 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $28,000 | $0 | $0 | $0 |
| Operating Expenses | $73,066 | $29,612 | $21,624 | $23,294 |
| Operating Income | -$62,074 | -$10,563 | $18,226 | -$22,705 |
| % Margin | -564.7% | -55.5% | 45.7% | -3,854.8% |
| Other Income/Exp. Net | $4,542 | $589 | -$23 | -$33,988 |
| Pre-Tax Income | -$57,532 | -$9,974 | $18,203 | -$56,693 |
| Tax Expense | $0 | $12 | $315 | $0 |
| Net Income | -$57,532 | -$9,986 | $17,888 | -$56,693 |
| % Margin | -523.4% | -52.4% | 44.9% | -9,625.3% |
| EPS | -2.15 | -0.46 | 0.9 | -3.82 |
| % Growth | -367.4% | -151.1% | 123.6% | – |
| EPS Diluted | -2.15 | -0.46 | 0.87 | -3.82 |
| Weighted Avg Shares Out | 26,716 | 21,590 | 19,931 | 14,853 |
| Weighted Avg Shares Out Dil | 26,716 | 21,590 | 20,597 | 14,853 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1,328 | $9 | $2 |
| Depreciation & Amortization | $10 | $6 | $4 | $4 |
| EBITDA | -$57,522 | -$9,968 | $18,216 | -$56,687 |
| % Margin | -523.3% | -52.3% | 45.7% | -9,624.3% |